For the Quarter Ending September 2025
North America
• In the United States, the Lincomycin Hydrochloride Price Index rose quarter-over-quarter in Q3 2025, driven by increased production costs.
• Production costs increased from a 2.6% PPI rise in August 2025 and strengthened natural gas prices in Q3 2025.
• Demand outlook was supported by a 5.42% retail sales increase in September 2025, boosting animal product consumption.
• US pharmaceutical market sentiment strengthened in Q3 2025, with surging drug approvals impacting Lincomycin Hydrochloride demand.
• Industrial electricity prices rose in September 2025, increasing manufacturing expenses for Lincomycin Hydrochloride producers.
• Overall chemical industry inventories remained elevated in Q3 2025, while manufacturing activity contracted.
• A 3.0% CPI increase in September 2025 indicated general inflation, raising operational costs for Lincomycin Hydrochloride manufacturers.
Why did the price of Lincomycin Hydrochloride change in September 2025 in North America?
• Production costs rose due to a 2.6% PPI increase in August 2025 and strengthened natural gas prices in Q3 2025.
• Demand was supported by a 5.42% retail sales increase in September 2025 and robust pharmaceutical market sentiment.
• General inflation, indicated by a 3.0% CPI increase in September 2025, raised overall operational expenses.
Europe
• In Germany, the Lincomycin Hydrochloride Price Index fell quarter-over-quarter in Q3 2025, influenced by easing producer prices and contracting industrial activity.
• Lincomycin Hydrochloride production costs faced mixed pressures; producer prices decreased by 1.7% year-on-year in September 2025.
• Moderate inflation, with CPI at 2.4% year-on-year in September 2025, contributed to rising raw material and industrial electricity costs.
• Demand for Lincomycin Hydrochloride was supported by moderate pharmaceutical market growth and robust healthcare spending in Q3 2025.
• Overall industrial production declined by 1.0% year-on-year in September 2025, and the Manufacturing Index contracted, dampening broader demand.
• A low unemployment rate of 3.9% in September 2025 supported purchasing power, yet negative consumer confidence (-23.6) limited discretionary spending.
• German chemical export orders trended weak in Q3 2025, with non-European market sales falling significantly, impacting trade flows.
• The Lincomycin Hydrochloride price forecast suggests continued stability with potential downward pressure due to weak industrial output and trade.
Why did the price of Lincomycin Hydrochloride change in September 2025 in Europe?
• Producer prices decreased by 1.7% year-on-year in September 2025, easing Lincomycin Hydrochloride input costs.
• Manufacturing Index contracted and industrial production declined 1.0% in September 2025, reducing demand.
• Robust healthcare spending and moderate pharmaceutical market growth in Q3 2025 provided demand resilience.
APAC
• In China, the Lincomycin Hydrochloride Price Index rose quarter-over-quarter in Q3 2025, driven by strengthening API export prices.
• Lincomycin Hydrochloride production costs increased during Q3 2025 due to elevated natural gas and global oil prices.
• Demand for Lincomycin Hydrochloride grew steadily in Q3 2025, supported by rising domestic generic drug consumption.
• In September 2025, the Consumer Price Index declined by 0.3%, indicating deflationary pressures on market sentiment.
• The Producer Price Index fell by 2.3% in September 2025, suggesting weak industrial demand and reduced pricing power.
• China's industrial production increased by 6.5% in September 2025, supporting economic growth and pharmaceutical demand.
• Retail sales grew by 3.0% in September 2025, reflecting stable consumer demand for human medicine applications.
• The Manufacturing Index contracted in September 2025, signaling a slowdown in the broader manufacturing sector.
• Consumer confidence remained cautious at 89.6 in September 2025, potentially impacting overall healthcare spending.
Why did the price of Lincomycin Hydrochloride change in September 2025 in APAC?
• Strengthening API export prices in China supported the Lincomycin Hydrochloride index in Q3 2025.
• Elevated natural gas and global oil prices increased Lincomycin Hydrochloride production costs.
• Steady API demand growth from generic and innovative drugs bolstered the Lincomycin Hydrochloride market.
For the Quarter Ending December 2022
North America
In the fourth quarter of 2022, Lincomycin Hydrochloride API costs decreased somewhat in North America, with CFR Los Angeles values dropping from $41850/mt to $41560/mt from October to December by 0.69%. The first week of October saw a delay in the imports of Lincomycin Hydrochloride due to a one-week holiday in exporting powerhouse China, but local demand was still strong.
Despite this, the domestic retailers' significant stock holdings and low demand for Lincomycin Hydrochloride during the second half kept prices in the US on the down. However, the protracted supply chain did start to mend as the economy expanded, and the port backlog dramatically decreased in November.
Asia Pacific
During the fourth quarter of 2022, the price of Lincomycin Hydrochloride across the Asia Pacific region displayed a downward price trajectory. Between October and December, FOB Shanghai prices in China decreased from $37980/mt to $36750/mt. Orders for Lincomycin Hydrochloride for China's API market slightly decreased during the first week of October Due to the closure of production facilities for the Golden Week. Domestic merchants encountered a lot of contradicting signals following a one-week holiday and the market's reopening, which made it difficult for the players to keep up with the slow development seen in the downstream industries. Offtakes in the pharmaceutical sectors remained consistent in terms of demand throughout the quarter. Due to criticism and widespread displeasure in the country, government authorities changed their zero-covid regulations, making the country vulnerable once more in the second half of the fourth quarter of 2022.
Europe
In Europe, the German market for Lincomycin Hydrochloride followed the same pattern as North America and Asia. The CFR Hamburg prices were resolved at $38450/mt in October and $38040/mt in December, indicating a downward trend. Offtakes were higher in the first part of the quarter than they were in December as a result of the unexpected rise in coronavirus infections, which caused a decrease in global demand in the latter weeks of December. But the economy as a whole continued to suffer from factors like COVID accidents and the conflict between Russia and Ukraine. Along with the easing of supply chain concerns, the CPI in Germany fell at the end of the year.
For the Quarter Ending September 2022
North America
In the third quarter of 2022, the price of Lincomycin Hydrochloride in North America showed a downward trend. However, throughout the first half of the quarter, the domestic market had an adequate supply of inventories to fulfill domestic demand from the end-user industries. Due to the heat wave and power shortage, several industrial facilities in China were forced to close during H2 of Q3. Several API manufacturing sites were under maintenance, negatively affecting US trade. Several businesses and industries blamed various factors for the drop in demand in the US, including the lasting effects of high inflation, supply shortages, rising interest rates, and increased uncertainty on the prognosis for the economy.
Asia- Pacific
The market for Lincomycin Hydrochloride in the Asia-Pacific region declined in the third quarter of 2022. In the Chinese market, FOB Shanghai prices decreased from USD 33450/MT to USD 31700/MT from July to September. Low raw material prices, subdued consumer spending, and slow end-user sector demand are some factors that have driven this price trend. Distributors only made orders for urgent use during the first half of this quarter due to the weak offtakes and the lackluster downstream demand. However, after the shutdown, several factories required maintenance, which impacted both local and international suppliers' availability of Lincomycin Hydrochloride, which occurred in the final week of July. Extreme weather and power outages have a further detrimental effect on China's market dynamics.
Europe
Prices for Lincomycin Hydrochloride in Germany decreased from USD 40360/MT to USD 39000/MT between July and September, signaling a reduction for the third quarter of 2022. Prices decreased with subdued market sentiment due to a decline in demand from the downstream pharmaceutical and nutraceutical sector. Also, abundant inventories were there to meet the overall demand resulting in a plunge in prices of Lincomycin Hydrochloride in the German market. This quarter, the logistical issues brought on by continued transportation delays and lengthy port congestion worsened Germany's economic crisis. The ongoing port restrictions in China and the unrest in Russia and Ukraine have worsened the business climate in Europe.
For the Quarter Ending June 2022
North America
North American region imports Lincomycin Hydrochloride API mainly from Asia-Pacific Countries, followed by their price trajectory throughout the second quarter of 2022. In April, CFR prices for Lincomycin Hydrochloride were discussed at USD 42100/MT, which is slightly on the lower side but started increasing from May due to strict policies in exporting countries caused by the resumption of the pandemic. Also, disruption in the supply chain as suppliers in China shut down production. Due to the shortage of containers, local downstream customers had trouble getting their hands on supplies. Increased downstream demand from the pharmaceutical industry keeps costs on the higher side. In June, the CFR New York prices for Lincomycin Hydrochloride in the USA settled at USD 44082/MT.
Asia- Pacific
At the onset of Q2, the market for Lincomycin Hydrochloride in the Asia-Pacific region, especially in China, opened with slightly lower prices due to adequate stock in the market. From May onwards, the prices of Lincomycin Hydrochloride continued to rise in the Chinese and Indian domestic markets. In China, prices increased from USD 31230/MT to USD 33300/MT FOB Shanghai from April to June, whereas in India, the prices surged to INR 2970000/MT Ex-Mumbai. The factor which affected the price trend was increased demand and limited supply in the regional market. The Chinese authorities imposed another lockdown in Shanghai due to the resurgence of COVID, which hindered the supply chain and supported the agitation in the spot market in Q2.
Europe
In the second quarter of 2022, the prices of Lincomycin Hydrochloride API in the European region showcased an upward price trajectory as the downstream pharmaceutical sector's demand for Lincomycin Hydrochloride rose. In Germany, the CFR Hamburg prices for Lincomycin Hydrochloride API settled at USD 39980/MT in June 2022, with an increase of 5.6%. Taking pressure from global crude oil values in the aftermath of the Russia-Ukraine war made significant players battle with the price revisions to protect their profit margin due to an increase in freight charges. However, reduced supply during the COVID resurgence in China has also resulted in an uptrend in the Lincomycin Hydrochloride API prices. The prices inclined drastically in Q2 2022 compared to the previous quarter.
